Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to assist users. The Intervention/Treatment header was reformatted to 'Intervention / Treatment' and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This typically reflects minor updates or fixes applied to the page content or documentation.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page footer no longer shows branding lines for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with the 'Helpful Links Provided by' label. This changes how the sponsoring institution is presented and credited on the page.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.5.4 replaces Revision: v3.5.3 on the page, signaling a behind-the-scenes software update. This change does not affect the study details or how the page presents information.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting an update to the site’s release/version without changing the underlying ClinicalTrials.gov study content.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.